Barclays lowered the firm’s price target on Clarivate (CLVT) to $4 from $5 and keeps an Underweight rating on the shares. The company reported “poor” Q4 results, pulled guidance, “questionable” buybacks, and a “Value Creation Plan” that does not appear large enough in scope to make a material difference, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLVT:
